DOI,paper_doi,paper_title_x,count_atlas,Publication_PMID,Publication_link,count_lnpdb,lnp_id,ionizable_lipid,peg_lipid,sterol_lipid,helper_lipid,lipid_molar_ratio,particle_size_nm_std,pdi_std,zeta_potential_mv_std,encapsulation_efficiency_percent_std,loading_capacity_std,target_type,nucleic_acid_sequence,peg_lipid_original,ionizable_lipid_original,helper_lipid_original,sterol_lipid_original,ionizable_lipid_smiles,peg_lipid_smiles,sterol_lipid_smiles,helper_lipid_smiles,synthesis_info,bioactivity_profile,paper_title_y,paper_authors,paper_journal,paper_year
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,949,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,99.9,0.145,4.36,77.0 ± 2.6 (Luc mRNA); 68.4 ± 3.2 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova, trp2",C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs, B16F10, B16-OVA; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 6.88±0.08E+04 RLU (in vitro macrophage), 1.8±0.4E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 31.7±5.6 IU/L, ALT: 132.3±22.4 IU/L, Histology: OK; cytokine_response: CTL lysis: 53.3±12.6%, ELISpot: 159.7±56.2 spots, Antibody titer: 200.3±25.7 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,950,A12-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,87.9,0.135,4.85,68.4 ± 2.8 (Luc mRNA); 76.1 ± 2.5 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A12-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN(C)C)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 5.01±0.80E+04 RLU (in vitro macrophage), 1.6±0.3E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 31.3±2.8 IU/L, ALT: 113.7±8.5 IU/L, Histology: OK; cytokine_response: CTL lysis: 27.2±1.7%, ELISpot: 14.7±2.5 spots, Antibody titer: 49.5±19.8 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,951,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,86.9,0.205,8.37,61.2 ± 3.7 (Luc mRNA); 85.8 ± 6.7 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A13-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN1CCCCC1,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 1.54±0.12E+05 RLU (in vitro macrophage), 2.0±0.2E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 29.6±8.1 IU/L, ALT: 124.3±52.4 IU/L, Histology: OK; cytokine_response: CTL lysis: 81.4±3.3%, ELISpot: 357.3±48.7 spots, Antibody titer: 258.3±62.8 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,952,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,89.6,0.159,4.54,63.4 ± 4.6 (Luc mRNA); 67.3 ± 3.5 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A17-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN1CC(C)CCC1CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 7.92±1.69E+04 RLU (in vitro macrophage), 2.7±0.4E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 31.5±4.0 IU/L, ALT: 128.3±13.3 IU/L, Histology: OK; cytokine_response: CTL lysis: 96.6±2.1%, ELISpot: 854.3±60.3 spots, Antibody titer: 457.2±22.2 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,953,A18-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,95.9,0.166,6.41,67.6 ± 5.1 (Luc mRNA); 70.3 ± 4.6 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova, e7, trp2",C14-PEG2000,A18-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2C(CCCC2)CC)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs, B16F10, TC-1, B16-OVA; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 4.01±0.60E+05 RLU (in vitro macrophage), 4.4±0.6E+08 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 29.5±1.5 IU/L, ALT: 134.3±4.3 IU/L, Histology: OK; cytokine_response: CTL lysis: 88.7±3.5%, ELISpot: 745.0±13.8 spots, Antibody titer: 379.4±23.2 RLU, strong STING pathway activation",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,954,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,97.9,0.125,4.37,61.2 ± 4.6 (Luc mRNA); 70.2 ± 6.3 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A21-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN1CCCCCC1,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 3.08±0.51E+05 RLU (in vitro macrophage), 1.6±0.05E+08 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 25.5±0.5 IU/L, ALT: 105.5±5.5 IU/L, Histology: OK; cytokine_response: CTL lysis: 93.2±2.8%, ELISpot: 478.0±71.2 spots, Antibody titer: 406.2±95.1 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,955,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,92.4,0.176,5.51,67.2 ± 2.9 (Luc mRNA); 64.3 ± 3.7 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A24-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN(CC)CC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 3.41±0.22E+04 RLU (in vitro macrophage), 1.2±0.1E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 31.5±0.5 IU/L, ALT: 117.5±6.5 IU/L, Histology: OK; cytokine_response: CTL lysis: 20.9±1.3%, ELISpot: 39.3±7.4 spots, Antibody titer: 116.3±73.2 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,956,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,95.9,0.21,6.41,67.5 ± 6.5 (Luc mRNA); 64.1 ± 4.5 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova, trp2",C14-PEG2000,A25-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN(CCCC)CCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 9.71±1.45E+04 RLU (in vitro macrophage), 1.4±0.2E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 27.5±2.5 IU/L, ALT: 124.5±5.5 IU/L, Histology: OK; cytokine_response: CTL lysis: 11.5±4.5%, ELISpot: 5.3±0.6 spots, Antibody titer: 30.2±1.9 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,957,Custom lipid,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,92.3,0.197,5.36,67.8 ± 2.4 (Luc mRNA); 68.5 ± 2.7 (OVA mRNA),WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova",C14-PEG2000,A26-Iso5-2DC18,DOPE,cholesterol,CCOC(=O)C1=NC(CCCCCCCCC=CCCCCCCCC)(CCCCCCCCC=CCCCCCCCC)CN1CCCN(CCC)CCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: Macrophages, HeLa, BMDCs, BMDMs; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: 1.43±0.05E+05 RLU (in vitro macrophage), 1.1±0.02E+07 (in vivo s.c. 0.5mg/kg); biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: AST: 39.3±5.8 IU/L, ALT: 122.7±10.5 IU/L, Histology: OK; cytokine_response: CTL lysis: 26.5±2.9%, ELISpot: 36.3±2.5 spots, Antibody titer: 40.3±1.8 RLU",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,958,DLin-MC3-DMA,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:16,80-150,<0.3,,50-70,WR:10(wt/wt)[lipid:mRNA],mRNA,"firefly_luciferase, ova, e7, trp2",C14-PEG2000,MC3,DOPE,cholesterol,CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, BMDCs, BMDMs, B16F10, TC-1, B16-OVA; animal_model: C57BL/6 mice; administration_route: subcutaneous; dose: 15 μg mRNA per mouse; gene_expression_result: control lipid for comparison; biodistribution_result: local injection site and draining lymph nodes; toxicity_profile: no observable toxicity; cytokine_response: minimal immune activation compared to cyclic lipids",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,959,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,45:2.5:42.5:10,87.6,0.2,,45.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS in 20,000 MWCO cassette at 4°C for 1h; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: subcutaneous; gene_expression_result: 6.0E+07 (optimized formulation),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,960,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:25,99.9,0.1,,61.3,WR:15(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.9E+07 RLU (in vivo i.m.), 2.2E+07 RLU (HeLa), 2.0E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,961,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,76.9,0.2,,55.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.5E+07 RLU (in vivo i.m.), 1.7E+07 RLU (HeLa), 2.0E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,962,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:2.9:31.1:16,101,0.2,,60.6,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 5.9E+07 RLU (in vivo i.m.), 6.9E+06 RLU (HeLa), 1.3E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,963,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,259.6,0.3,,25.5,WR:2.9(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.1E+07 RLU (in vivo i.m.), 1.2E+07 RLU (HeLa), 2.2E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,964,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:0.5:57.5:7,115.9,0.3,,64.7,WR:5(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 7.5E+06 RLU (in vivo i.m.), 1.2E+07 RLU (HeLa), 6.1E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,965,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,65:0.5:27.5:7,137.9,0.2,,57.9,WR:15(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 7.9E+06 RLU (in vivo i.m.), 1.4E+04 RLU (HeLa), 4.8E+03 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,966,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,65:2.5:7.5:25,167.9,0.2,,22.5,WR:5(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 1.1E+07 RLU (in vivo i.m.), 4.9E+06 RLU (HeLa), 2.7E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,967,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,122.4,0.3,,96.4,WR:17.1(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 9.6E+06 RLU (in vivo i.m.), 3.5E+06 RLU (HeLa), 9.7E+05 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,968,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,95.9,0.2,,59.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.2E+07 RLU (in vivo i.m.), 1.7E+07 RLU (HeLa), 1.6E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,969,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,71.2:1.5:11.3:16,72.3,0.2,,56.4,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.0E+06 RLU (in vivo i.m.), 4.2E+06 RLU (HeLa), 9.2E+05 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,970,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,94,0.2,,68.1,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.2E+07 RLU (in vivo i.m.), 2.5E+07 RLU (HeLa), 1.6E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,971,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,28.8:1.5:53.7:16,84.9,0.2,,64.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 4.2E+07 RLU (in vivo i.m.), 1.5E+07 RLU (HeLa), 2.0E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,972,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,65:2.5:25.5:7,127.8,0.2,,57.2,WR:5(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 1.9E+07 RLU (in vivo i.m.), 4.0E+06 RLU (HeLa), 5.5E+05 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,973,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,84.9,0.2,,57.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.1E+07 RLU (in vivo i.m.), 1.4E+07 RLU (HeLa), 1.8E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,974,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:55.5:7,108.7,0.1,,65.2,WR:15(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 1.9E+07 RLU (in vivo i.m.), 9.9E+06 RLU (HeLa), 1.7E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,975,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:45.2:3.3,94.9,0.3,,21.7,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.0E+07 RLU (in vivo i.m.), 7.6E+06 RLU (HeLa), 3.8E+05 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,976,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:32.5:16,91.8,0.2,,70.2,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.2E+07 RLU (in vivo i.m.), 1.9E+07 RLU (HeLa), 1.8E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,977,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:0.5:39.5:25,129.4,0.2,,53.9,WR:5(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.2E+06 RLU (in vivo i.m.), 2.0E+07 RLU (HeLa), 3.7E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,978,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:19.8:28.7,83.2,0.3,,41.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 7.7E+06 RLU (in vivo i.m.), 5.2E+06 RLU (HeLa), 8.6E+05 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,979,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,65:0.5:9.5:25,110.7,0.1,,98.9,WR:15(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 9.8E+05 RLU (in vivo i.m.), 1.1E+04 RLU (HeLa), 3.5E+04 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,980,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:0.1:33.9:16,154.9,0.1,,9.4,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.9E+05 RLU (in vivo i.m.), 3.7E+06 RLU (HeLa), 2.2E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,981,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,102.5,0.2,,60.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C","cell_line: HeLa, B16F10; animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 5.3E+07 RLU (in vivo i.m.), 6.3E+06 RLU (HeLa), 1.1E+06 RLU (B16F10)",Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,982,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:1.5:23.5:25,119.8,0.3,,79,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.2E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,983,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,102.5,0.2,,60.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 5.5E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,984,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:46.5:16,110.6,0.1,,50.4,WR:15(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.15E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,985,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:37.5:25,105.5,0.2,,60.3,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.13E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,986,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:34.5:28,108.6,0.2,,45.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.58E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,987,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.5:42.5:20,112.5,0.1,,54.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 2.67E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,988,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,50:2.5:37.5:10,94.8,0.1,,75.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 7.70E+06 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,989,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,45:2.5:36.5:16,115.6,0.2,,76.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 1.96E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,990,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,45:2.5:42.5:10,87.6,0.2,,45.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 6.0E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,991,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:1.5:47.5:16,140.6,0.1,,55.5,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 3.04E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
10.1038/s41587-019-0247-3,https://doi.org/10.1038/s41587-019-0247-3,Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,44,31570898.0,https://www.nature.com/articles/s41587-019-0247-3,1128,992,A2-Iso5-2DC18,C14-PEG2000,cholesterol,DOPE,35:2.8:46.2:16,88.6,0.2,,65.6,WR:10(wt/wt)[lipid:mRNA],mRNA,firefly_luciferase,C14-PEG2000,A2-Iso5-2DC18,DOPE,cholesterol,CCCCCCCC/C=C\CCCCCCCC1(N(C(N=C1)C(=O)OCC)CCCN2CCCC2)CCCCCCC/C=C\CCCCCCCC,CCCCCCCCCCCCCCOC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC,"synthesis_method: Microfluidic; device_used: microfluidic chip device; total_flow_rate_ml_min: ; flow_rate_ratio: 3:1 (ethanol:aqueous); aqueous_phase_composition: 10mM citrate buffer (pH 3.0); organic_phase_composition: ethanol; mixing_time_sec: ; temperature_condition: room temperature; post_processing: dialysis against 1X PBS; sterilization: ; storage_buffer: 1X PBS, stored at 4°C",animal_model: C57BL/6 mice; administration_route: intramuscular; gene_expression_result: 4.91E+07 RLU (in vivo i.m.),Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation,"['Lei Miao', 'Linxian Li', 'Yuxuan Huang', 'Derfogail Delcassian', 'Jasdave Chahal', 'Jinsong Han', 'Yunhua Shi', 'Kaitlyn Sadtler', 'Wenting Gao', 'Jiaqi Lin', 'Joshua C. Doloff', 'Robert Langer', 'Daniel G. Anderson']",Nature Biotechnology,2019.0
